Please login to the form below

Not currently logged in
Email:
Password:

Nabriva Therapeutics names Elyse Seltzer as CMO

She joins from GlaxoSmithKline

Clinical stage biopharma firm Nabriva Therapeutics has appointed Elyse Seltzer as chief medical officer.

The company is engaged on the research and development on novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics.

In her new role, Seltzer will supervise medical and regulatory aspects of clinical development and medical affairs, contributing to the company's clinical development strategy.

Commenting on her appointment, Seltzer said: “I am thrilled to join Nabriva. I am excited to have the opportunity to advance a novel class of antibacterials, particularly given the current and evolving challenges around resistance to currently available antibiotics. 

"I look forward to working with the highly experienced clinical team to fulfil this goal."

Seltzer joins Nabriva from GSK, where she was VP of global clinical sciences and operations. Prior to this, Seltzer was CMO at Tengion, a regenerative medicine company.

Dr Colin Broom, CEO of Nabriva, added: “We are very pleased to welcome Elyse to Nabriva. Her extensive experience in the anti-infective therapeutic area, and in leading international clinical development programs will enable us to efficiently advance our lead product, lefamulin, into late stage development for the treatment of CABP.”

Seltzer assumes the role from Dr William Prince, who will take up the position of senior VP of clinical science.

27th May 2015

From: Research

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Flu
Influenza – the risk to vulnerable populations
Why we can't get complacent about flu vaccination...
dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...
Data security
Concerns about data security are building a strong case for clinical mobility in EMEA
Electronic medical records have transformed the storage of sensitive information but how can the healthcare sector continue to protect patient and staff data?...